Contineum Therapeutics, Inc. Class A CTNM
NASDAQ · United States · Health Technology
$13.12+0.13 (+1.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.40 | -0.45 | +10.9% | $0 | — | +7.7%$14.38→$15.49 |
| Q1 2026 | 2026-05-05 | -0.39 | -0.55 | +29.1% | — | — | +5.6%$14.15→$14.94 |
| Q4 2025 | 2026-03-05 | -0.49 | -0.39 | -25.6% | — | — | -6.6%$14.86→$13.88 |
| Q3 2025 | 2025-10-30 | -0.45 | -0.58 | +22.4% | — | — | +1.0%$10.90→$11.01 |
| Q4 2024 | 2025-03-06 | -0.56 | -0.43 | -30.2% | — | — | — |
| Q1 2024 | 2024-05-16 | -3.55 | -1.33 | -166.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.